Further studies have found that Foxa1 and Foxa2 can mediate and enhance the regulation of ERα or androgen receptor (AR) on target genes during the formation of liver cancer, thereby inhibiting (ERα) or promoting (AR) the development of liver cancer (38). The gene discussed is AR; the disease is liver cancer.